Barclays
IMI

Barclays’s Intermolecular, Inc. IMI Stock Holding History

Barclays’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-374,403
Closed -$490K – 7495
2018
Q1 		$490K Buy
+374,403
New +$533K ﹤0.01% 4005
2014
Q3 		– Sell
-67
Closed – – 7920
2014
Q2 		$0 Sell
67
-15,205
-100% -$38K ﹤0.01% 7896
2014
Q1 		$30K Buy
15,272
+12,879
+538% +$46.9K ﹤0.01% 6379
2013
Q4 		$9K Buy
2,393
+307
+15% +$1.73K ﹤0.01% 7037
2013
Q3 		$10K Sell
2,086
-238
-10% -$1.5K ﹤0.01% 6800
2013
Q2 		$17K Buy
+2,324
New +$19.8K ﹤0.01% 6920

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Barclays's IMI Position: Q2 2018 in Review

Barclays sold out of Intermolecular, Inc. (IMI) in Q2 2018, closing a stake of 374,403 shares — an estimated $490K sold.

Barclays first reported a position in IMI in Q2 2013 and held it in 6 quarters. The position peaked at $490K in Q1 2018. 25 funds tracked by Wall St. Rank hold IMI as of Q2 2018.

  • Barclays reported no remaining Intermolecular, Inc. position as of Q2 2018 after selling out during the quarter.
  • Barclays sold 374,403 Intermolecular, Inc. shares in Q2 2018, an estimated $490K.
  • Barclays first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 6 quarters.
  • Barclays's Intermolecular, Inc. position peaked at $490K in Q1 2018.
  • 25 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2018.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.